Scott Norberg

6PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 09, 2025
CD22 TCR-engineered T cells exert antileukemia cytotoxicity without causing inflammatory responses.

Kilyna A Nguyen, Zhihui Liu, John S Davies

|Nov 18, 2024
Adoptive transfer of membrane-restricted IL-12-TCR T cells promotes antigen spreading and elimination of antigen-negative tumor variants.

Ling Zhang, Scott M Norberg, Farrah Karimipour

|Jul 26, 2023
Multi-tiered approach to detect autoimmune cross-reactivity of therapeutic T cell receptors.

Kazusa Ishii, John S Davies, Andrew L Sinkoe

|Jul 06, 2022
Non-synergy of PD-1 blockade with T-cell therapy in solid tumors.

John S Davies, Farrah Karimipour, Ling Zhang

|Aug 31, 2021
Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis.

Yvette Robbins, Jay Friedman, Paul E Clavijo

Pageof 1